JM Ritter

633 total citations
13 papers, 208 citations indexed

About

JM Ritter is a scholar working on Physiology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, JM Ritter has authored 13 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Pharmacology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in JM Ritter's work include Nitric Oxide and Endothelin Effects (5 papers), Inflammatory mediators and NSAID effects (4 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). JM Ritter is often cited by papers focused on Nitric Oxide and Endothelin Effects (5 papers), Inflammatory mediators and NSAID effects (4 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). JM Ritter collaborates with scholars based in United Kingdom. JM Ritter's co-authors include JR Cockcroft, Phil Chowienczyk, N. Bender, Nigel Benjamin, J. Beacham, M H Thom, A. E. Johnston, E. Milne, Pablo Forte and Nigel Benjamin and has published in prestigious journals such as British Journal of Clinical Pharmacology, Regulatory Peptides and Perfusion.

In The Last Decade

JM Ritter

13 papers receiving 197 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JM Ritter United Kingdom 7 90 76 50 35 25 13 208
JR Cockcroft United Kingdom 5 117 1.3× 73 1.0× 47 0.9× 33 0.9× 20 0.8× 12 221
María Ofelia Barber Fox Cuba 7 136 1.5× 44 0.6× 36 0.7× 25 0.7× 75 3.0× 19 332
Shuji Mukae Japan 9 133 1.5× 77 1.0× 60 1.2× 26 0.7× 84 3.4× 14 306
Eiry Edmunds United Kingdom 8 173 1.9× 11 0.1× 45 0.9× 29 0.8× 35 1.4× 16 313
Gürkan Sengoelge Austria 11 13 0.1× 56 0.7× 37 0.7× 94 2.7× 84 3.4× 14 341
Bernardo López Andrade Spain 10 90 1.0× 11 0.1× 90 1.8× 20 0.6× 71 2.8× 27 320
H. B. Steinhauer Germany 9 67 0.7× 23 0.3× 39 0.8× 39 1.1× 47 1.9× 17 286
Claudia E. Ramirez United States 10 109 1.2× 57 0.8× 49 1.0× 18 0.5× 59 2.4× 16 372
Laura L. Norling United States 10 131 1.5× 12 0.2× 25 0.5× 14 0.4× 144 5.8× 22 339
Fraser Witherow United Kingdom 6 145 1.6× 77 1.0× 11 0.2× 54 1.5× 21 0.8× 11 247

Countries citing papers authored by JM Ritter

Since Specialization
Citations

This map shows the geographic impact of JM Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JM Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JM Ritter more than expected).

Fields of papers citing papers by JM Ritter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JM Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JM Ritter. The network helps show where JM Ritter may publish in the future.

Co-authorship network of co-authors of JM Ritter

This figure shows the co-authorship network connecting the top 25 collaborators of JM Ritter. A scholar is included among the top collaborators of JM Ritter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JM Ritter. JM Ritter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ritter, JM. (2009). Methods in Clinical Pharmacology. British Journal of Clinical Pharmacology. 68(1). 1–3. 3 indexed citations
2.
Forte, Pablo, E. Milne, Phil Chowienczyk, et al.. (1998). Evidence for a Difference in Nitric Oxide Biosynthesis between Healthy Women and Men. Clinical Science. 94(s38). 8P–8P. 4 indexed citations
3.
Fleming, John, et al.. (1995). The haemodynamic effects of the thromboxane A2 receptor antagonist GR32191 B during cardiopulmonary bypass in the dog. Perfusion. 10(6). 403–413. 2 indexed citations
4.
Cockcroft, JR, et al.. (1994). Inhibition of bradykinin‐induced vasodilation in human forearm vasculature by icatibant, a potent B2‐receptor antagonist.. British Journal of Clinical Pharmacology. 38(4). 317–321. 80 indexed citations
5.
Cockcroft, JR, et al.. (1994). Effect of NG‐monomethyl‐L‐arginine on kinin‐induced vasodilation in the human forearm.. British Journal of Clinical Pharmacology. 38(4). 307–310. 51 indexed citations
6.
Cockcroft, JR, et al.. (1993). Lack of effect of enalaprilat on the action of vasoactive intestinal polypeptide in the human forearm.. British Journal of Clinical Pharmacology. 35(5). 525–527. 1 indexed citations
7.
Cockcroft, J.R., et al.. (1992). Effect of peptide YY on the blood flow response to vasoactive intestinal peptide in the human forearm vascular bed. Regulatory Peptides. 40(2). 228–228. 1 indexed citations
8.
Benjamin, Nigel, et al.. (1991). Ouabain and responses to endothelium‐dependent vasodilators in the human forearm.. British Journal of Clinical Pharmacology. 32(6). 758–760. 7 indexed citations
9.
Benjamin, Nigel, et al.. (1991). Sensitivity to angiotensin II of forearm resistance vessels in pregnancy.. British Journal of Clinical Pharmacology. 32(4). 523–525. 15 indexed citations
10.
Ritter, JM, et al.. (1990). Effects of a selective thromboxane receptor antagonist (GR32191B) and of glyceryl trinitrate on bleeding time in man.. British Journal of Clinical Pharmacology. 29(4). 431–436. 6 indexed citations
11.
Ritter, JM, et al.. (1989). Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man.. British Journal of Clinical Pharmacology. 28(5). 573–579. 22 indexed citations
12.
Ritter, JM, et al.. (1983). Multicentre controlled trial of tienilic acid in hyperuricaemic, hypertensive subjects, with intensive monitoring of liver function.. British Journal of Clinical Pharmacology. 15(5). 513–518. 3 indexed citations
13.
Ritter, JM, et al.. (1983). Cardiovascular and platelet effects in man of BW 245C, a stable mimic of epoprostenol (PGI2).. British Journal of Clinical Pharmacology. 15(5). 509–511. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JR Cockcroft Breakdown of academic impact, for papers by María Ofelia Barber Fox Breakdown of academic impact, for papers by Shuji Mukae Breakdown of academic impact, for papers by Eiry Edmunds Breakdown of academic impact, for papers by Gürkan Sengoelge Breakdown of academic impact, for papers by Bernardo López Andrade Breakdown of academic impact, for papers by H. B. Steinhauer Breakdown of academic impact, for papers by Claudia E. Ramirez Breakdown of academic impact, for papers by Laura L. Norling Breakdown of academic impact, for papers by Fraser Witherow
Rankless by CCL
2026